A carregar...

Radium-223 dichloride in Combination with Vascular Endothelial Growth Factor-Targeting Therapy in Advanced Renal Cell Carcinoma with Bone Metastases

PURPOSE: This study investigates the biologic activity of radium-223 with vascular endothelial growth factor (VEGF)-targeted therapy in patients with advanced renal cell carcinoma (aRCC) and bone metastases. EXPERIMENTAL DESIGN: Fifteen treatment-naïve patients (n=15) received pazopanib 800 mg orall...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Cancer Res
Main Authors: McKay, Rana R., Bossé, Dominick, Gray, Kathryn P., Michaelson, M. Dror, Krajewski, Katherine, Jacene, Heather A., Walsh, Meghara, Bellmunt, Joaquim, Pomerantz, Mark, Harshman, Lauren C., Choueiri, Toni K.
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6688176/
https://ncbi.nlm.nih.gov/pubmed/29848570
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-17-3577
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!